Download PDF
Dtsch Med Wochenschr 2001; 126(50): 1440-1447
DOI: 10.1055/s-2001-18975
Fachgremien & Konsensuskonferenzen
© Georg Thieme Verlag Stuttgart · New York

Therapie von Pilzinfektionen in der Hämatologie und Onkologie

Leitlinien der Arbeitsgemeinschaft Infektionen in der Hämatologie und Onkologie (AGIHO) der Deutschen Gesellschaft für Hämatologie und Onkologie (DGHO)Treatment of fungal infections in haematology and oncology. Guidelines of the Working Party on Infections in Haematology and Oncology (AGIHO) of the German Society for Haematology and Oncology (DGHO)A. Böhme1 , M. Ruhnke 2 , M. Karthaus3 , H. Einsele4 , S. Guth 5 , G. Heußel6 , C. P. Heußel7 , C. Junghanss 8 , W. V. Kern9 , T. Kubin10 , O. Sezer 2 , G. Silling11 , T. Südhoff12 , H. Szelényi 13 , A. J. Ullmann6
  • 1Med. Klin. III (Direktor: D. Hoelzer), J. W. Goethe-Universität Frankfurt
  • 2Abt. Innere Med., Schwerp. Hämatologie/Onkologie (Direktor: K. Possinger), Charité, Campus Mitte der Humboldt-Universität zu Berlin
  • 3Med. Klinik II, Ev. Johannes-Krankenhaus (Leiter: M. Karthaus) Bielefeld
  • 4Med. Klinik u. Poliklinik, Abt. und Lehrstuhl II (Direktor: L. Kanz), Univ.klinikum Tübingen
  • 5Klinik u. Poliklinik für Herz-, Thorax- und Gefäßchirurgie (Direktor: H. Oelert), Johannes Gutenberg-Universität Mainz
  • 6III. Med. Klinik u. Poliklinik (Direktor: Ch. Huber), Johannes Gutenberg-Universität Mainz
  • 7Klinik u. Poliklinik für Radiologie (Direktor: M. Thelen), Johannes Gutenberg-Universität, Mainz
  • 8Abt. Hämatologie/Onkologie (Direktor: M. Freund), Univ.klinikum Rostock
  • 9Innere Med. III, (Direktor: H. Döhner), Univ. Ulm
  • 10II. Medizin, Hämatologie/Onkologie/Infektionskrankheiten (Direktor: J. Th. Fischer), Städt. Klinikum Karlsruhe
  • 11Med. Klinik A, Hämatologie/Onkologie, KMT-Zentrum (Direktor: W.E. Berdel), Westfälische-Wilhelms-Universität Münster
  • 12Medizinische Klinik (Direktor: W. Schmiegel) der Ruhr-Universität, Knappschaftskrankenhaus Bochum
  • 13Med. Klinik III, Schwerpunkt Hämatologie, Onkologie u. Transfusionsmedizin (Direktor: E. Thiel), Univ.klinikum Benjamin Franklin Berlin
Further Information

Publication History

Publication Date:
13 December 2001 (online)

Also available at
    Permissions and Reprints

The Infectious Diseases Working Party of the German Society of Hematology and Oncology presents their guidelines for the treatment of fungal infections in patients with hematological and oncological malignancies. These guidelines are evidence-based considering study results, case reports and expert opinions using the evidence criteria of the Infectious Diseases Society of America (IDSA). They offer actual standards and open questions in the treatment of oropharyngeal and esophageal candidosis, invasive candida infections, cryptococcosis, aspergilloses and mucormycoses. Recommendations for the use and handling of amphotericin B, amphotericin B lipid formulations, azoles and combination therapy are given as well as informations about investigational drugs. Surgical procedures, treatment with hematopoietic growth factors and innovative approaches such as granulocyte transfusion are discussed.

Literatur

  • 1 Ahmad S R, Singer S J, Leissa B G. Congestive heart failure associated with itraconazole.  Lancet. 2001;  357 1766-1767
    Google Scholar
  • 2 Anaissie E, Bodey G P, Kantarjian H. et al . Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior AmB therapy.  Am J Med. 1991;  91 142-150
    Google Scholar
  • 3 Bernard A, Caillot D, Couaillier J F, Casasnovas O, Guy H, Favre J P. Surgical management of invasive pulmonary aspergillosis in neutropenic patients.  Ann Thorac Surg. 1997;  64 1441-1447
    Google Scholar
  • 4 Böhme A, Karthaus M, Einsele H. et al . Diagnostik systemischer Pilzinfektionen in der Hämatologie. Standardempfehlungen der Arbeitsgemeinschaft Infektiologie in der Hämatologie und Onkologie der Deutschen Gesellschaft für Hämatologie und Onkologie.  Dtsch Med Wochenschr. 1999;  124 24-30 (suppl))
    Google Scholar
  • 5 Caillot D, Casasnovas O, Bernard A. et al . Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.  J Clin Oncol. 1997;  15 139-147
    Google Scholar
  • 6 Caillot D, Durand C, Casasnovas O. et al . Invasive pulmonary aspergillosis in neutropenic patients. Analysis of a series of 36 cases: contribution of thoracic scanners and itraconazole.  Ann Med Interne. 1995;  146 84-90
    Google Scholar
  • 7 Denning D W. Invasive aspergillosis.  Clin Infect Dis. 1998;  26 781-805
    Google Scholar
  • 8 Ellis M, Spence D, de Pauw B. et al . An EORTC international multicenter randomized trial (EORTC number 19 923) comparing two dosages of liposomal AmB for treatment of invasive aspergillosis.  Clin Infect Dis. 1998;  27 1406-1412
    Google Scholar
  • 9 Edwards J E Jr, Bodey G P, Bowden R A. et al . International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.  Clin Infect Dis. 1997;  25 43-59
    Google Scholar
  • 10 Eriksson U, Seifert B, Schaffner A. Comparison of effects of AmB deoxycholate infused over 4 or 24 hours: randomized controlled trial.  Br Med J. 2001;  322 1-6
    Google Scholar
  • 11 Fätkenheuer G, Buchheidt D, Fuhr H -G. et al . Venenkatheter-assoziierte Infektionen bei Patienten in Neutropenie.  Dtsch Med Wochenschr. 2000;  126 89-95
    Google Scholar
  • 12 Glasmacher A, Hahn C, Leutner C. et al . Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole.  Mycoses. 1999;  42 443-451
    Google Scholar
  • 13 Habicht J M, Reichenberger F, Gratwohl A, Zerkowski H R, Tamm M. Surgical aspects of resection for suspected invasive pulmonary fungal infection in neutropenic patients.  Ann Thorac Surg. 1999;  68 321-325
    Google Scholar
  • 14 Heussel C P, Kauczor H U, Heussel G, Mildenberger P, Dueber C. Aneurysms complicating inflammatory diseases in immunocompromised hosts: value of contrast-enhanced CT.  Eur Radiol. 1997;  7 316-319
    Google Scholar
  • 15 Hübel K, Dale D C, Engert A, Liles W C. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases.  J Infect Dis. 2001;  183 321-328
    Google Scholar
  • 16 Karthaus M, Huebner G, Elser C, Geissler R G, Heil G, Ganser A. Early detection of chronic disseminated Candida infection in leukemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation.  Ann Hematol. 1998;  77 41-45
    Google Scholar
  • 17 Llanos A, Cieza J, Bernardo J. et al . Effect of salt supplementation on AmB nephrotoxicity.  Kidney Int. 1991;  40 302-308
    Google Scholar
  • 18 Leenders A CAP, Daenen S, Jansen R LH. et al . Liposomal AmB compared with AmB deoxycholate in the treatment of documented and suspected neutropenia-induced invasive fungal infections.  Br J Haematol. 1998;  103 205-212
    Google Scholar
  • 19 Leenders A C, Reiss P, Portegies P. et al . Liposomal AmB (AmBisome) compared with AmB both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.  AIDS. 1997;  11 1463-1471
    Google Scholar
  • 20 Link H, Blumenstengel K, Böhme A. et al . Antimikrobielle Therapie von ungeklärtem Fieber bei Neutropenie. Standardempfehlungen der Arbeitsgemeinschaft Infektiologie in der Hämatologie und und Onkologie der Deutschen Gesellschaft für Hämatologie und Onkologie.  Dtsch Med Wochenschr. 1999;  124 3-8 (suppl))
    Google Scholar
  • 21 Maschmeyer G, Beinert T h, Buchheidt D, Einsele H, Holler E. Diagnostik und Therapie von Lungeninfiltraten bei febrilen neutropenischen Patienten. Standardempfehlungen der Arbeitsgemeinschaft Infektiologie in der Hämatologie und und Onkologie der Deutschen gesellschaft für Hämatologie und Onkologie.  Dtsch Med Wochenschr. 1999;  124 18-23 (suppI))
    Google Scholar
  • 22 Munk P L, Vellet A D, Rankin R N, Muller N L, Ahmad D. Intracavitary aspergilloma: transthoracic percutaneous injection of amphotericin gelatin solution.  Radiology. 1993;  188 821-823
    Google Scholar
  • 23 Musa M O, Al E isa A, Halim M. et al . The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years.  Brit J Haematol. 2000;  108 544-548
    Google Scholar
  • 24 Neely M N, Ghannoum M A. The exciting future of antifungal therapy.  Eur J Clin Microbiol Infect Dis. 2000;  19 897-914
    Google Scholar
  • 25 Offner F. Hematopoietic growth factors in cancer patients with invasive fungal infections.  Eur J Clin Microbiol Infect Dis. 1997;  16 56-63
    Google Scholar
  • 26 Oldfield E C, Garst P D, Hostettler C, White M, Samuelson D. Randomized, double-blind trial of 1- versus 4-hour AmB infusion durations.  Antimicrob Agents Chemother. 1990;  34 1402-1406
    Google Scholar
  • 27 Ozer H, Armitage J O, Bennett L. et al . 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines.  J Clin Oncol. 2000;  18 3558-3585
    Google Scholar
  • 28 Pagano L, Ricci P, Tonso A. et al . Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases.  Br J Haematol. 1997;  99 331-336
    Google Scholar
  • 29 Patterson T F. et al . Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes.  Medicine. 2000;  79 260
    Google Scholar
  • 30 Peters C, Minkov M, Matthes-Martin S. et al . Leukocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients.  Br J Haematol. 1999;  106 689-696
    Google Scholar
  • 31 Phillips P. et al . A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.  Clin Infect Dis. 1998;  26 1368-1373
    Google Scholar
  • 32 Price T H, Bowden R A, Boeckh M. et al . Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation.  Blood. 2000;  95 3302-3309
    Google Scholar
  • 33 Rex J H, Bennett J E, Sugar A M. et al. Candidemia Study Group and the National Institute . A randomized trial comparing fluconazole with AmB for the treatment of candidemia in patients without neutropenia.  N Engl J Med. 1994;  331 1325-1330
    Google Scholar
  • 34 Rex J H, Walsh T J, Sobel J D. et al . Practice guidelines for the treatment of candidiasis.  Clin Infect Dis. 2000;  30 662-678
    Google Scholar
  • 35 Saag M S, Graybill R J, Larsen R A. Practice guidelines for the management of cryptococcal disease.  Clin Infect Dis. 2000;  30 710-718
    Google Scholar
  • 36 Salerno C T, Ouyang D W, Pederson T S. et al . Surgical therapy for pulmonary aspergillosis in immunocompromised patients.  Ann Thorac Surg. 1998;  65 1415-1419
    Google Scholar
  • 37 DeShazo R D, Chapin K, Swain R E. Fungal sinusitis.  N Engl J Med. 1997;  337 254-259
    Google Scholar
  • 38 Sobel J D. for the Mycoses Study Group . Practice guidelines for the treatment of fungal infections.  Clin Infect Dis. 2000;  30 652
    Google Scholar
  • 39 Sobel J D, Vazquez J A. Fungal infections of the urinary tract.  World J Urol. 1999;  17 410-414
    Google Scholar
  • 40 Stevens D A, Kann V L, Judson M A. et al . Practice guidelines for diseases caused by aspergillus.  Clin Infect Dis. 2000;  30 696-709
    Google Scholar
  • 41 Stevens D A, Lee J Y. Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group Criteria.  Arch Intern Med. 1997;  157 1857-1862
    Google Scholar
  • 42 Tedder M, Spratt J A, Anstadt M P, Hedge S S, Tedder S D, Lowe J E. Pulmonary mucormycosis: results of medical and surgical therapy.  Ann Thorac Surg. 1994;  57 1044-1050
    Google Scholar
  • 43 Van der Horst C M, Saag M S, Cloud G A. et al . Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.  N Engl J Med. 1997;  337 15-21
    Google Scholar
  • 44 Verweij P E, Donnelly J P, Kullberg B J, Meis J F, Pauw G M. AmB versus AmB plus flucytosine: poor results in the treatment of proven systemic mysoses in neutropenic patients.  Infection. 1994;  22 81-85
    Google Scholar
  • 45 Walsh T J. Primary cutaneous aspergillosis - an emerging infection among immunocompromised patients.  Clin Infect Dis. 1998;  27 453-457
    Google Scholar
  • 46 Walsh T J. et al . Liposomal AmB for empirical therapy in patients with persistent fever and neutropenia.  N Engl J Med. 1999;  340 764-771
    Google Scholar
  • 47 Walsh T J, Hiemenz J W, Seibel N L. et al . AmB lipid complex for invasive fungal infections.  Clin Infect Dis. 1998;  26 1383-1396
    Google Scholar
  • 48 Wilcox C M, Darouiche R O, Laine L, Moskovitz B L, Mallegol I, Wu J. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.  J Infect Dis. 1997;  176 227-232
    Google Scholar
  • 49 Einsele H, Bertz H, Beyer J, Kiehl M G, Runde V, Kolb HJ, Holler E, Beck R, Schwerdfeger R, Schumacher U, Hebart H, Martin H, Kienast J, Ullmann A J, Maschmeyer G, Krüger W, Link H, Schmidt C A, Oettle H, Klingebiel T. für die Arbeitsgemeinschaft Infektionen der Deutschen Gesellschaft für Hämatologie und Onkologie . Epidemiologie und interventionelle Therapiestrategien infektiöser Komplikationen nach allogener Stammzelltransplantation.   Dtsch Med Wochenschr. 2001;  126 1278-1284
    Google Scholar

Korrespondenz

PD Dr. Angelika Böhme*

Med. Klin III, J.W. Goethe-Universität

Theodor-Stern-Kai 7

60590 Frankfurt

Phone: 069/63015194

Fax: 069/63017326

Email: A. boehme@em.uni-frankfurt.de

*gefördert vom BMBF Kompetenznetz Akute und chronische Leukämien

      >